Pyridoxal 5'-Phosphate

DRUG2 trials

Sponsors

Medicure, Colorado State University

Conditions

Receptor BlockadeTardive Dyskinesia

Early Phase 1

Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults

CompletedNCT03738943

Colorado State UniversityReceptor Blockade

Start: 2019-02-07End: 2021-06-01Updated: 2021-07-27

Phase 2

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

TerminatedNCT00917293

MedicureTardive Dyskinesia

Start: 2009-05-31End: 2014-08-31Updated: 2019-02-15